In pursuance of the Company's Code of Conduct for prevention of Insider Trading in terms of SEBI (Prohibition of Insider Trading) Regulations and Code of Practices and Procedure for fair disclosure of Unpublished Price Sensitive Information, Medicamen Biotech has informed that the trading window was closed for the Directors, Designated Employees of the Company, other specified persons, its's subsidiaries and Insiders from July 1, 2022 till the declaration of Financial Results of the Company for the quarter and year ended on June 30, 2022 and the two days thereafter. The date of the Board Meeting of the Company for declaration of financial results for the quarter and year ended on June 30, 2022 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
